Skip to main content
OpenTrials

Clinical trial condition

Stage IVB Hypopharyngeal Carcinoma AJCC v8

Explore clinical trials studying Stage IVB Hypopharyngeal Carcinoma AJCC v8. Study availability and eligibility vary by location and protocol.

10 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Stage IVB Hypopharyngeal Carcinoma AJCC v8 trial results

Recruiting

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

NCT05172245

Conditions
Carcinoma, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +43 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kansas Clinical Research Center Fairway, Kansas, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
View all 18 locations
View Trial Details
Recruiting

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NCT06532279

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +62 more
Locations
  • Arizona Center for Cancer Care - Gilbert Gilbert, Arizona, United States
  • Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States
  • Arizona Center for Cancer Care - Phoenix Phoenix, Arizona, United States
  • Arizona Center for Cancer Care - Scottsdale Scottsdale, Arizona, United States
View all 153 locations
View Trial Details
Completed

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

NCT03258554

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +38 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
View all 256 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin

NCT04533750

Conditions
Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous Cell Carcinoma, +34 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 27 locations
View Trial Details

Related conditions